CDKN2A and neoplasm: To directly assess the potential role of Arf knockout in the non-tumor cell compartment in influencing tumor progression, we performed orthotopic experiments wherein tumor cells derived from a RIP-Tag2; Arf+/+ tumor were injected into the pancreas of immunocompetent Arf+/+ or Arf−/− mice, and tumor size was measured four weeks later.